Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Apodemus prepares and tests PI4Kbeta inhibitors

Jan. 11, 2017

Topline results from phase III study of glecaprevir/pibrentasvir for HCV in Japanese patients

Jan. 10, 2017

Viamet Pharmaceuticals reports results from phase II studies of VT-1161

Jan. 10, 2017

AiCuris begins clinical development of AIC-4998

Jan. 9, 2017

Aridis Pharmaceuticals' AR-301 shows promising results in phase I/IIa study

Jan. 9, 2017

PaxVax, NIH and DoD form chikungunya vaccine partnership

Jan. 9, 2017

Genocea Biosciences reports interim results from phase IIb trial of GEN-003

Jan. 9, 2017

ContraVir Pharmaceuticals awarded grant to advance hepatitis B treatment

Jan. 5, 2017

Phase III trial to compare delafloxacin to moxifloxacin in community-acquired bacterial pneumonia

Jan. 2, 2017

Basilea Pharmaceutica develops antibacterial activity enhancers

Dec. 30, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...